AI/ML Innovations Inc. (AIMLF) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist AI/ML Innovations Inc. (AIMLF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026AI/ML Innovations Inc. (AIMLF) Gesundheitswesen & Pipeline-Uebersicht
AI/ML Innovations Inc. develops AI and machine learning-driven digital healthcare solutions, including a personal health monitoring system and wearable tech. Targeting caregivers, patients, and healthcare professionals, the company aims to improve recovery outcomes. It operates in the competitive healthcare information services sector, facing established and emerging players.
Investmentthese
AI/ML Innovations Inc. operates in the high-growth digital healthcare market, driven by increasing adoption of AI and ML technologies. However, the company's negative profit margin of -3910.2% and gross margin of -249.6% raise concerns about its financial sustainability. A potential catalyst is the further development and commercialization of its patent-pending health monitoring system. Key risks include the need for significant capital to scale operations and competition from larger, more established players in the healthcare information services sector. Investors should closely monitor the company's ability to improve its financial performance and secure strategic partnerships.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- AI/ML Innovations Inc. operates in the digital healthcare sector, focusing on AI and machine learning applications.
- The company's personal health monitoring system is patent-pending, potentially offering a competitive advantage.
- The company's profit margin is -3910.2%, indicating significant losses.
- The company's gross margin is -249.6%, suggesting challenges in cost management.
- The company's market capitalization is $0.00B, reflecting its small size and early stage of development.
Wettbewerber & Vergleichsunternehmen
Staerken
- Patent-pending personal health monitoring system.
- Focus on AI and machine learning in healthcare.
- Integrated digital health solutions.
- Potential for data-driven insights.
Schwaechen
- Negative profit margin and gross margin.
- Limited market presence and brand recognition.
- Dependence on external funding.
- Small market capitalization.
Katalysatoren
- Upcoming: Potential partnerships with healthcare providers to expand market reach.
- Ongoing: Development and commercialization of the patent-pending health monitoring system.
- Ongoing: Expansion of the company's digital health software offerings.
- Upcoming: Securing additional funding to support growth initiatives.
- Ongoing: Increasing adoption of AI and ML technologies in the healthcare sector.
Risiken
- Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.
- Potential: Intense competition from larger, more established players in the healthcare information services sector.
- Potential: Regulatory hurdles and compliance requirements could delay product development and commercialization.
- Potential: Dependence on external funding to support operations and growth.
- Ongoing: Low liquidity and price volatility due to OTC listing.
Wachstumschancen
- Expansion of the personal health monitoring system: The company's patent-pending personal health monitoring system presents a significant growth opportunity. By expanding the system's capabilities and targeting specific patient populations, AI/ML Innovations can increase its market share. The market for remote patient monitoring is projected to reach $175.2 billion by 2027, offering a substantial addressable market.
- Strategic partnerships with healthcare providers: Collaborating with hospitals, clinics, and other healthcare providers can accelerate the adoption of AI/ML Innovations' solutions. These partnerships can provide access to a wider patient base and facilitate the integration of the company's technology into existing healthcare workflows. This is an ongoing opportunity as healthcare providers increasingly seek digital solutions.
- Development of new wearable technologies: The company can leverage its expertise in AI and ML to develop new wearable technologies that address specific healthcare needs. These technologies can provide real-time data and insights, enabling more proactive and personalized care. The global wearable medical devices market is expected to reach $29.6 billion by 2029, presenting a significant growth avenue.
- Geographic expansion into new markets: AI/ML Innovations can expand its reach by targeting new geographic markets. This can involve adapting its solutions to meet the specific needs of different regions and establishing partnerships with local distributors and healthcare providers. This is an ongoing opportunity as the company seeks to broaden its global footprint.
- Data analytics and insights: Leveraging the data collected through its health monitoring system and wearable technologies, AI/ML Innovations can provide valuable insights to healthcare providers and patients. This can involve developing predictive models, identifying trends, and personalizing treatment plans. The market for healthcare analytics is projected to reach $75 billion by 2026, offering a significant growth opportunity.
Chancen
- Expansion into new geographic markets.
- Strategic partnerships with healthcare providers.
- Development of new wearable technologies.
- Increasing adoption of digital health solutions.
Risiken
- Intense competition from larger, more established players.
- Regulatory hurdles and compliance requirements.
- Rapid technological advancements.
- Economic downturns and reduced healthcare spending.
Wettbewerbsvorteile
- Patent-Pending Technology: The patent-pending personal health monitoring system provides a degree of exclusivity.
- Data-Driven Insights: The ability to collect and analyze data to provide valuable insights.
- Integrated Solutions: Offering a comprehensive suite of digital health solutions.
- Focus on AI/ML: Specialization in artificial intelligence and machine learning within the healthcare sector.
Ueber AIMLF
AI/ML Innovations Inc., formerly AIML Resources Inc., was incorporated in 2009 and rebranded in November 2020 to reflect its focus on artificial intelligence and machine learning within the healthcare sector. Headquartered in Victoria, Canada, the company develops and markets digital health solutions, including a patent-pending personal health monitoring and management system. This system is designed for use by caregivers, patients, and healthcare professionals, providing tools to access and utilize data to improve recovery outcomes and promote healthy living. AI/ML Innovations also develops digital health software and wearable technologies. The company's core focus is leveraging AI and ML to create innovative solutions that address the evolving needs of the healthcare industry, with an emphasis on personalized health management and improved patient outcomes. The company aims to establish itself as a key player in the digital healthcare market by offering integrated and data-driven solutions.
Was das Unternehmen tut
- Develop a patent-pending personal health monitoring and management system.
- Create digital health software solutions.
- Design and market wearable technologies for healthcare.
- Provide data-driven insights for caregivers and healthcare professionals.
- Offer solutions for enhanced recovery outcomes.
- Focus on promoting healthy living through technology.
Geschaeftsmodell
- Software as a Service (SaaS): Recurring revenue from subscriptions to the health monitoring system.
- Wearable Technology Sales: Revenue from the sale of wearable devices.
- Data Analytics Services: Revenue from providing data analytics and insights to healthcare providers.
- Partnerships: Revenue from strategic partnerships with healthcare providers and distributors.
Branchenkontext
AI/ML Innovations Inc. operates within the rapidly expanding digital healthcare market, which is experiencing significant growth due to the increasing adoption of AI and machine learning technologies. The market is characterized by intense competition, with established players and emerging startups vying for market share. Key trends include the rise of personalized medicine, remote patient monitoring, and data-driven healthcare solutions. Competitors include companies like Ayr Wellness Inc. (AYRWF), Ayr Strategies Inc. (AYURF), and CM Life Sciences Inc. (CMHSF). AI/ML Innovations aims to carve out a niche by offering integrated and user-friendly digital health solutions.
Wichtige Kunden
- Caregivers: Providing tools to monitor and manage the health of their patients or loved ones.
- Patients: Empowering individuals to take control of their health and recovery.
- Healthcare Professionals: Offering data-driven insights to improve patient care and outcomes.
Finanzdaten
Chart & Info
AI/ML Innovations Inc. (AIMLF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer AIMLF verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer AIMLF.
Kursziele
Wall-Street-Kurszielanalyse fuer AIMLF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von AIMLF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: John Paul Duffy
CEO
John Paul Duffy is the CEO of AI/ML Innovations Inc. His background includes experience in technology and business development, with a focus on identifying and capitalizing on emerging market trends. He has a track record of leading companies through periods of growth and innovation. Duffy's expertise lies in strategic planning, market analysis, and building strong teams to execute on business objectives. He is committed to driving AI/ML Innovations Inc.'s mission of transforming healthcare through AI and machine learning.
Erfolgsbilanz: Under John Paul Duffy's leadership, AI/ML Innovations Inc. has focused on developing its patent-pending personal health monitoring system and expanding its digital health software offerings. He has overseen the company's rebranding to reflect its focus on AI and ML. Duffy has also been instrumental in forging strategic partnerships and securing funding to support the company's growth initiatives. Key milestones include the launch of the health monitoring system and the expansion of the company's customer base.
AIMLF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that AI/ML Innovations Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited Financial Disclosure: The lack of comprehensive financial reporting increases the risk of investing in AIMLF.
- Low Liquidity: The low trading volume can make it difficult to buy or sell shares.
- Price Volatility: The stock price may be subject to significant fluctuations.
- Potential for Fraud: The OTC Other tier is more susceptible to fraudulent activities.
- Regulatory Scrutiny: AIMLF may face increased regulatory scrutiny due to its OTC listing.
- Verify the company's management team and their track record.
- Review any available financial statements and assess the company's financial health.
- Research the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory filings or legal issues.
- Assess the company's long-term growth potential.
- Focus on AI and machine learning in healthcare.
- Development of a patent-pending personal health monitoring system.
- Presence of a CEO with relevant experience.
- Company's stated mission to transform healthcare through technology.
- Headquartered in Canada, a country with strong corporate governance standards.
AI/ML Innovations Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for AIMLF?
AI/ML Innovations Inc. (AIMLF) currently holds an AI score of 46/100, indicating low score. Key strength: Patent-pending personal health monitoring system.. Primary risk to monitor: Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.. This is not financial advice.
How frequently does AIMLF data refresh on this page?
AIMLF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AIMLF's recent stock price performance?
Recent price movement in AI/ML Innovations Inc. (AIMLF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patent-pending personal health monitoring system.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AIMLF overvalued or undervalued right now?
Determining whether AI/ML Innovations Inc. (AIMLF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AIMLF?
Before investing in AI/ML Innovations Inc. (AIMLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding AIMLF to a portfolio?
Potential reasons to consider AI/ML Innovations Inc. (AIMLF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Patent-pending personal health monitoring system.. Additionally: Focus on AI and machine learning in healthcare.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of AIMLF?
Yes, most major brokerages offer fractional shares of AI/ML Innovations Inc. (AIMLF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track AIMLF's earnings and financial reports?
AI/ML Innovations Inc. (AIMLF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for AIMLF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is limited and may not be fully up-to-date.
- OTC market stocks carry higher risks than exchange-listed stocks.
- AI analysis is pending and not yet factored into this report.